Titan Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 5.06

TTNP Stock  USD 7.38  0.15  2.07%   
Titan Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Titan Pharmaceuticals. Implied volatility approximates the future value of Titan Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Titan Pharmaceuticals over a specific time period. For example, 2024-05-17 PUT at $5.0 is a PUT option contract on Titan Pharmaceuticals' common stock with a strick price of 5.0 expiring on 2024-05-17. The contract was last traded on 2023-10-24 at 11:33:51 for $4.6 and, as of today, has 50 days remaining before the expiration. The option is currently trading at a bid price of $4.4, and an ask price of $4.9. The implied volatility as of the 28th of March is 267.99. View All Titan options

Closest to current price Titan long PUT Option Payoff at Expiration

Titan Pharmaceuticals' future price is the expected price of Titan Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Titan Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Titan Pharmaceuticals Backtesting, Titan Pharmaceuticals Valuation, Titan Pharmaceuticals Correlation, Titan Pharmaceuticals Hype Analysis, Titan Pharmaceuticals Volatility, Titan Pharmaceuticals History as well as Titan Pharmaceuticals Performance.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.
  
At this time, Titan Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 03/28/2024, Price Earnings To Growth Ratio is likely to grow to 2.31, while Price To Operating Cash Flows Ratio is likely to drop (24.20). Please specify Titan Pharmaceuticals' target price for which you would like Titan Pharmaceuticals odds to be computed.

Titan Pharmaceuticals Target Price Odds to finish over 5.06

The tendency of Titan Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 5.06  in 90 days
 7.38 90 days 5.06 
about 97.0
Based on a normal probability distribution, the odds of Titan Pharmaceuticals to stay above $ 5.06  in 90 days from now is about 97.0 (This Titan Pharmaceuticals probability density function shows the probability of Titan Stock to fall within a particular range of prices over 90 days) . Probability of Titan Pharmaceuticals price to stay between $ 5.06  and its current price of $7.38 at the end of the 90-day period is about 65.16 .
Given the investment horizon of 90 days Titan Pharmaceuticals has a beta of -1.92. This usually implies as returns on its benchmark rise, returns on holding Titan Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Titan Pharmaceuticals is expected to outperform its benchmark. Moreover Titan Pharmaceuticals has an alpha of 1.0592, implying that it can generate a 1.06 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Titan Pharmaceuticals Price Density   
       Price  

Predictive Modules for Titan Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Titan Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Titan Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.367.3714.38
Details
Intrinsic
Valuation
LowRealHigh
0.336.5813.59
Details
Naive
Forecast
LowNextHigh
0.877.8914.90
Details
1 Analysts
Consensus
LowTargetHigh
6.377.007.77
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Titan Pharmaceuticals. Your research has to be compared to or analyzed against Titan Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Titan Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Titan Pharmaceuticals.

Titan Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Titan Pharmaceuticals is not an exception. The market had few large corrections towards the Titan Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Titan Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Titan Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
1.06
β
Beta against NYSE Composite-1.92
σ
Overall volatility
0.97
Ir
Information ratio 0.09

Titan Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Titan Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Titan Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Titan Pharmaceuticals had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 52 K. Net Loss for the year was (6.17 M) with loss before overhead, payroll, taxes, and interest of (4.37 M).
Titan Pharmaceuticals currently holds about 6.42 M in cash with (6.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Titan Pharmaceuticals has a poor financial position based on the latest SEC disclosures
Roughly 48.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Joseph Akers of 25000 shares of Titan Pharmaceuticals at 4.02 subject to Rule 16b-3

Titan Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Titan Stock often depends not only on the future outlook of the current and potential Titan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Titan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.4 M
Cash And Short Term Investments2.9 M
Shares Float401 K

Titan Pharmaceuticals Technical Analysis

Titan Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Titan Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Titan Pharmaceuticals. In general, you should focus on analyzing Titan Stock price patterns and their correlations with different microeconomic environments and drivers.

Titan Pharmaceuticals Predictive Forecast Models

Titan Pharmaceuticals' time-series forecasting models is one of many Titan Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Titan Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Titan Pharmaceuticals

Checking the ongoing alerts about Titan Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Titan Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Titan Pharmaceuticals had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 52 K. Net Loss for the year was (6.17 M) with loss before overhead, payroll, taxes, and interest of (4.37 M).
Titan Pharmaceuticals currently holds about 6.42 M in cash with (6.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Titan Pharmaceuticals has a poor financial position based on the latest SEC disclosures
Roughly 48.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Joseph Akers of 25000 shares of Titan Pharmaceuticals at 4.02 subject to Rule 16b-3
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:

Complementary Tools for Titan Stock analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.20)
Revenue Per Share
0.409
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.61)
Return On Equity
(1.06)
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.